CeQur, a developer of wearable delivery devices, has started a clinical study of PaQ insulin delivery device. The PaQ study is conducted by Thomas Pieber, head of endocrinology and metabolism division at Austria University Hospital. The ...
Tags: CeQur, clinical study, PaQ insulin delivery device, PaQ study
Medtronic has introduced the Endurant II AAA Stent Graft system in the US, following the US Food and Drug Administration's (FDA) approval. The Endurant II AAA Stent Graft system is designed for the treatment of abdominal aortic aneurysms ...
Tags: Medtronic, Endurant II AAA Stent Graft system, FDA, EVAR
Medtronic has begun its minimally invasive Symplicity renal denervation system's clinical trial in Japan to treat patients who are not responding to different types of anti-hypertensive medications and are at risk of stroke. The ...
Cook Medical has presented three-year data from Zilver PTX trial, which demonstrated 70.7% primary patency in the superficial femoral artery at 36 months using Paclitaxel-eluting stents. The controlled, randomized trail compares to ...
Tags: Zilver PTX trial, clinical study, clinical application, Cook Medical
Boulder Diagnostics, a developer of new diagnostic technologies, has launched Lyme Borreliosis disease test as a diagnostic service in Europe. The SpiroFind test, which is offered by the company's clinical diagnostic service ...
Tags: clinical trial, diagnostic technology, Boulder Diagnostics
Endosense, a provider of cardiac technologies, has completed enrolling patients in its Toccastar clinical study. The prospective, randomized, multi-center investigational device exemption trial, which enrolled 300 patients with ...
Tags: Endosense, Toccastar clinical study, cardiac technologies
Boston Scientific has received the US Food and Drug Administration (FDA) approval for 32 mm and 38 mm lengths of the Promus Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent system. The Promus Element Stent is made with a ...
Tags: FDA, Boston Scientific, Promus Element Stent, coronary artery disease
Echo Therapeutics has reported positive results from a clinical study of its Symphony tCGM system, designed to provide real-time blood glucose data continuously and cost-effectively. Designed as a non-invasive, wireless, transdermal ...
Tags: Echo Therapeutics, clinical study, Symphony tCGM system, CG-EGA
The US Food and Drug Administration (FDA) has granted approval to Pulmonx to commence an investigational device exemption (IDE) pivotal clinical study of its Zephyr Endobronchial Valve (EBV) therapy, designed to treat emphysema. The ...
Tags: FDA, Endobronchial Valve therapy, emphysema, Zephyr EBV therapy
Abiomed has received US Food and Drug Administration's (FDA) investigational device exemption (IDE) to begin a pivotal clinical study of its Impella Right-side Percutaneous (RP ) pump. The percutaneous heart pump is implanted through a ...
Tags: percutaneous heart pump, Impella Right-side Percutaneous pump, FDA
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to STENTYS to conduct a pivotal APPOSITION V clinical study for its Self-Apposing stent. The Self-Apposing technology, which adapts vessels with ...
ConvaTec has unveiled enhanced Flexi-Seal Signal fecal management system (FMS) in the US. Flexi-Seal FMS is indicated for patients with little or no bowel control and liquid or semi-liquid stool, and can be used for up to 29 consecutive ...
Tags: ConvaTec, Flexi-Seal FMS, sampling port, Healthy rectal mucosa
SinuSys has obtained CE mark for its AerOs Sinus Dilation system, designed to open the maxillary ostia (openings that connect a sinus to the nasal cavity) and treat painful chronic sinusitis. The low pressure, self-expanding AerOs device ...
Tags: SinuSys, AerOs System, sinus disease
Auxogyn has obtained CE mark approval for its non-invasive early embryo viability assessment (Eeva) test, designed to improve in vitro fertilization (IVF) outcomes. By using intelligent computer vision software, Eeva test measures ...
The US Food and Drug Administration (FDA) has cleared Boston Scientific's subcutaneous implantable cardioverter defibrillator (S-ICD) to treat patients at risk for sudden cardiac arrest (SCA). The CE-marked system, which the company ...
Tags: FDA, CE-marked system, S-ICD system